Search

everythinglearnresearchcommunity

for

Search:↓

Chemotherapy-induced hair loss is partly due to decreased laminin-511 and increased laminin-332.

Topical IKKα inhibitors may help prevent CCS tumours.

Lhx2 is a crucial regulator of the Sonic Hedgehog signaling in early mouse retinal development.

New LPA receptors (LPA4, LPA5, LPA6) have diverse roles in the body.

Ribonucleotide excision repair is crucial to prevent skin cancer.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Lipid metabolism affects wool thickness in sheep.

FOXN1 gene variants cause low T cells and immune issues from birth.

Skin tumors with CYLD cutaneous syndrome show more NF-κB activity and less organized collagen.

Lipid nanoparticles improve treatment delivery and are key to future therapies, but challenges in manufacturing and safety remain.

Ribonucleotide excision repair is crucial to prevent skin cancer.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Loss of Pten in certain hair follicle stem cells increases skin cancer risk.

LGR5 is a common marker of hair follicle stem cells in different animals and is important for hair growth and regeneration.

Lhx2 is essential for effective Sonic Hedgehog signaling in early retinal development.

LPAR6 has a unique way of binding and activating, which helps in designing treatments for hair loss and cancer.

The Foxn1(-/-) nude mouse shows disrupted and expanded skin stem cell areas due to high Lhx2 levels.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

Key genes linked to immune response are highly active in lupus-affected hair follicles.

Certain miRNAs may play a role in sheep hair follicle development, which could help improve wool production.

Hairless protein is key for hair growth, cell differences cause gene expression variation, and the N-end rule pathway senses nitric oxide for protein breakdown.

miR-200a reduces goose fibroblast growth by targeting PITX2 in the Wnt pathway.

Developing microRNA-based treatments is hard but has potential.

Super-enhancers control CD25 expression in specific cell types, affecting immune function.

ETS2 drives cancer progression in squamous cell carcinoma and is linked to poor patient outcomes.

Lysophosphatidic acid affects sensory neurons and may cause neuropathic pain and itch.

Monoclonal antibodies LT-1, LT-2, and LT-7 help diagnose certain blood cancers.

Nanotechnology improves CRISPR-Cas9 delivery for cancer treatment, but challenges remain.